| Literature DB >> 33504658 |
Manish Sadarangani1,2, Tobias Kollmann3, Gordean Bjornson4, Paul Heath5, Ed Clarke6, Arnaud Marchant7, Ofer Levy8,9,10, Elke Leuridan11, Rolando Ulloa-Gutierrez12, Clare L Cutland13, Beate Kampmann6,14, Surasith Chaithongwongwatthana15, Ener Dinleyici16, Pierre van Damme11, Flor M Munoz17,18.
Abstract
Despite significant progress in reaching some milestones of the United Nations Sustainable Development Goals, neonatal and early infant morbidity and mortality remain high, and maternal health remains suboptimal in many countries. Novel and improved preventative strategies with the potential to benefit pregnant women and their infants are needed, with maternal and neonatal immunization representing effective approaches. Experts from immunology, vaccinology, infectious diseases, clinicians, industry, public health, and vaccine-related social sciences convened at the 5th International Neonatal and Maternal Immunization Symposium (INMIS) in Vancouver, Canada, from 15 to 17 September 2019. We critically evaluated the lessons learned from recent clinical studies, presented cutting-edge scientific progress in maternal and neonatal immunology and vaccine development, and discussed maternal and neonatal immunization in the broader context of infectious disease epidemiology and public health. Focusing on practical aspects of research and implementation, we also discussed the safety, awareness, and perception of maternal immunization as an existing strategy to address the need to improve maternal and neonatal health worldwide. The symposium provided a comprehensive scientific and practical primer as well as an update for all those with an interest in maternal and neonatal infection, immunity, and vaccination. The summary presented here provides an update of the current status of progress in maternal and neonatal immunization.Entities:
Keywords: immunology; implementation; infant; integration; maternal immunization; neonatal; vaccination; vaccine acceptance; vaccine safety; vaccines in pregnancy
Mesh:
Substances:
Year: 2021 PMID: 33504658 PMCID: PMC7885317 DOI: 10.1128/mSphere.00862-20
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389